scholarly journals Clinical assessment of sacroiliitis and HLA-B27 are poor predictors of sacroiliitis diagnosed by magnetic resonance imaging in psoriatic arthritis

Rheumatology ◽  
2004 ◽  
Vol 43 (1) ◽  
pp. 85-88 ◽  
Author(s):  
L. Williamson
2013 ◽  
Vol 65 (9) ◽  
pp. 2274-2278 ◽  
Author(s):  
Concepción Castillo-Gallego ◽  
Sibel Z. Aydin ◽  
Paul Emery ◽  
Dennis G. McGonagle ◽  
Helena Marzo-Ortega

2020 ◽  
Vol 7 ◽  
Author(s):  
Daniel B. Abrar ◽  
Christoph Schleich ◽  
Anja Müller-Lutz ◽  
Miriam Frenken ◽  
K. Ludger Radke ◽  
...  

2012 ◽  
Vol 39 (2) ◽  
pp. 408-412 ◽  
Author(s):  
MIKKEL ØSTERGAARD ◽  
RENÉ PANDURO POGGENBORG

The potential of magnetic resonance imaging (MRI) for use in clinical practice and research has gained increasing interest over the last decade. International collaborative initiatives from GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis) and/or OMERACT (Outcome Measures in Rheumatology) may contribute to facilitating research, identifying appropriate areas for use, and reaching consensus on the optimal examination technique. Accordingly, GRAPPA, a primary driver of international research in psoriasis and psoriatic arthritis (PsA), has focused on the current use and future development of MRI and other modern imaging modalities in PsA. This review, presented at the GRAPPA 2010 annual meeting, describes the current status of MRI in PsA, with a focus on its use in diagnosis, monitoring, and prediction of the disease course and treatment response. Important areas for future research are also outlined.


Sign in / Sign up

Export Citation Format

Share Document